BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
2 Horne J. Why REM sleep? Clues beyond the laboratory in a more challenging world. Biological Psychology 2013;92:152-68. [DOI: 10.1016/j.biopsycho.2012.10.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
3 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 McGregor R, Wu MF, Barber G, Ramanathan L, Siegel JM. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J Neurosci 2011;31:15455-67. [PMID: 22031892 DOI: 10.1523/JNEUROSCI.4017-11.2011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
5 Steiner MA, Lecourt H, Jenck F. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat. Int J Neuropsychopharmacol 2013;16:417-32. [PMID: 22436395 DOI: 10.1017/S1461145712000193] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
6 Matsuki T, Takasu M, Hirose Y, Murakoshi N, Sinton CM, Motoike T, Yanagisawa M. GABAA receptor-mediated input change on orexin neurons following sleep deprivation in mice. Neuroscience 2015;284:217-24. [PMID: 25286384 DOI: 10.1016/j.neuroscience.2014.09.063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
7 Monti JM. The neurotransmitters of sleep and wake, a physiological reviews series. Sleep Med Rev 2013;17:313-5. [PMID: 23602125 DOI: 10.1016/j.smrv.2013.02.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
8 Fitch TE, Benvenga MJ, Jesudason CD, Zink C, Vandergriff AB, Menezes MM, Schober DA, Rorick-Kehn LM. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Front Neurosci 2014;8:5. [PMID: 24478625 DOI: 10.3389/fnins.2014.00005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
9 Mavanji V, Perez-Leighton CE, Kotz CM, Billington CJ, Parthasarathy S, Sinton CM, Teske JA. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area. Sleep 2015;38:1361-70. [PMID: 25845696 DOI: 10.5665/sleep.4970] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
10 Pan L, Qi R, Wang J, Zhou W, Liu J, Cai Y. Evidence for a Role of Orexin/Hypocretin System in Vestibular Lesion-Induced Locomotor Abnormalities in Rats. Front Neurosci 2016;10:355. [PMID: 27507932 DOI: 10.3389/fnins.2016.00355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Godden KE, Landry JP, Slepneva N, Migues PV, Pompeiano M. Early expression of hypocretin/orexin in the chick embryo brain. PLoS One 2014;9:e106977. [PMID: 25188307 DOI: 10.1371/journal.pone.0106977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
12 Deutschman CS, Raj NR, McGuire EO, Kelz MB. Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 2013;41:e368-75. [PMID: 24105451 DOI: 10.1097/CCM.0b013e31828e9843] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
13 Modi HR, Wang Q, Gd S, Sherman D, Greenwald E, Savonenko AV, Geocadin RG, Thakor NV. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation. PLoS One 2017;12:e0182707. [PMID: 28957432 DOI: 10.1371/journal.pone.0182707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
14 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
15 Vassalli A, Dellepiane JM, Emmenegger Y, Jimenez S, Vandi S, Plazzi G, Franken P, Tafti M. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children. Brain 2013;136:1592-608. [PMID: 23616586 DOI: 10.1093/brain/awt069] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
16 Black SW, Morairty SR, Chen TM, Leung AK, Wisor JP, Yamanaka A, Kilduff TS. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy. J Neurosci 2014;34:6485-94. [PMID: 24806675 DOI: 10.1523/JNEUROSCI.0080-14.2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
17 Siegel JM. REM sleep: a biological and psychological paradox. Sleep Med Rev 2011;15:139-42. [PMID: 21482156 DOI: 10.1016/j.smrv.2011.01.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
18 Aran A, Shors I, Lin L, Mignot E, Schimmel MS. CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans. Sleep 2012;35:187-91. [PMID: 22294808 DOI: 10.5665/sleep.1618] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
19 Hu B, Yang N, Qiao QC, Hu ZA, Zhang J. Roles of the orexin system in central motor control. Neurosci Biobehav Rev 2015;49:43-54. [PMID: 25511388 DOI: 10.1016/j.neubiorev.2014.12.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]